Dynavax Technologies
DVAX
#5495
Rank
$1.27 B
Marketcap
$10.89
Share price
-0.64%
Change (1 day)
-15.12%
Change (1 year)

Earnings for Dynavax Technologies (DVAX)

Earnings in 2025 (TTM): -$33.89 Million USD

According to Dynavax Technologies 's latest financial reports the company's current earnings are $0.33 Billion USD. In 2024 the company made an earning of $37.65 Million USD, an increase over its 2023 earnings that were of $2.39 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Dynavax Technologies from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -$33.89 Million-190.01%
2024 $37.65 M1475.31%
2023 $2.39 M-99.2%
2022 $0.30 B238.78%
2021 $88.69 M-257.89%
2020 -$56.18 Million-58.58%
2019 -$0.14 Billion-9.32%
2018 -$0.15 Billion60.44%
2017 -$93.22 Million-15.8%
2016 -$0.12 Billion4.22%
2015 -$0.11 Billion16.54%
2014 -$91.15 Million37.09%
2013 -$66.49 Million
2010 -$47.59 Million214.85%
2009 -$15.12 Million-37.33%
2008 -$24.12 Million-66.07%
2007 -$71.1 Million16.92%
2006 -$60.81 Million170.36%
2005 -$22.49 Million33.39%
2004 -$16.86 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
$20.66 M-160.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$1.90 B-5,718.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$23.09 B-68,236.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$9.88 B-29,272.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
$13.09 B-38,727.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
$9.32 B-27,610.92%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
$11.85 B-35,074.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
$1.77 B-5,328.99%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
$8.24 B-24,427.20%๐Ÿ‡บ๐Ÿ‡ธ USA